Blackrock, INC Schedule 13G passive stakes

BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 8.3% in Celldex Therapeutics, Inc. as of December 31, 2024.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.3% beneficial ownership stake in Dynex Capital Inc. as of December 31, 2024.

BlackRock, Inc. has disclosed an increased beneficial ownership of 12.2% in EverQuote Inc.'s common stock as of December 31, 2024, according to a recent Schedule 13G filing.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.5% beneficial ownership stake in Interactive Brokers Group Inc.'s Class A Common Stock as of December 31, 2024.

Investment giant BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.4% beneficial ownership stake in quantum computing company IonQ, Inc. as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting a 5.4% passive beneficial ownership stake in Cipher Mining Inc. as of December 31, 2024.

Investment giant BlackRock, Inc. has reported a 7.3% beneficial ownership stake in software company Gitlab Inc. as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.0% of Intapp, Inc.'s common stock as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, revealing an 8.8% beneficial ownership stake in the iShares MSCI Denmark ETF as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting a passive beneficial ownership of 5.3% in KKR & Co. Inc. as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting a 5.1% beneficial ownership stake in Provident Bancorp, Inc. as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting a passive beneficial ownership of 6.6% of V2X, Inc.'s common stock as of December 31, 2024.

BlackRock, Inc. has reported a 5.3% beneficial ownership stake in Avis Budget Group Inc., holding over 1.8 million shares of common stock as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting a 5.8% beneficial ownership stake in Bright Horizons Family Solutions Inc. as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting a passive beneficial ownership of 5.7% in Carvana Co.'s Class A common stock as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, revealing a 5.1% beneficial ownership stake in Columbia Sportswear Co. as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting a 6.1% beneficial ownership stake in the iShares MSCI USA Equal Weighted ETF as of December 31, 2024, indicating a passive investment intent.

BlackRock, Inc. has filed a Schedule 13G, reporting a 9.4% beneficial ownership stake in the iShares MSCI Germany ETF as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 8.6% of the common stock of iShares MSCI Netherlands ETF as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting a passive beneficial ownership of 5.3% in the iShares MSCI ACWI ex U.S. ETF as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting a 7.6% beneficial ownership stake in the iShares Short Treasury Bond ETF as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, revealing a passive beneficial ownership of 5.1% in Larimar Therapeutics, Inc. as of December 31, 2024.

BlackRock, Inc. has reported a beneficial ownership of 5.3% of Unity Bancorp Inc.'s common stock, totaling 526,171 shares, as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, disclosing a 5.2% beneficial ownership stake in SFL Ltd as of December 31, 2024, held in the ordinary course of business.

BlackRock, Inc. has filed a Schedule 13G, reporting a 5.0% beneficial ownership stake in Shopify Inc. as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, revealing a 5.9% beneficial ownership stake in Ballard Power Systems Inc. as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, revealing a passive beneficial ownership of 5.2% of CAE INC's common stock as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, revealing a significant beneficial ownership of 5.7% in Royalty Pharma PLC as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting a passive beneficial ownership of 8.4% of Flex LTD's common stock as of December 31, 2024.

BlackRock, Inc. has filed a Schedule 13G, reporting a 6.8% beneficial ownership stake in AppLovin Corp as of December 31, 2024.